SCYNEXIS Inc. appointed Marion McCourt as a board member.
McCourt was most recently COO of biopharmaceutical company Medivation Inc. until it was acquired by Pfizer Inc. in September 2016. Her appointment expands SCYNEXIS' board to eight members.
SCYNEXIS appoints director
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
SCYNEXIS Inc. appointed Marion McCourt as a board member.
McCourt was most recently COO of biopharmaceutical company Medivation Inc. until it was acquired by Pfizer Inc. in September 2016. Her appointment expands SCYNEXIS' board to eight members.